002610.SZ
Jiangsu Akcome Science and Technology Co., Ltd. [002610.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002610.SZ Stock Summary
Top 10 Correlated ETFs
002610.SZ
Top 10 Correlated Stocks
002610.SZ
In the News
002610.SZ Financial details
Company Rating
Buy
Market Cap
8.13B
Income
-526.34M
Revenue
6.08B
Book val./share
0.64
Cash/share
0.4
Dividend
-
Dividend %
-
Employees
1.48K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
-22.59
Forward P/E
-
PEG
-9.71
P/S
1.83
P/B
4.13
P/C
4.2
P/FCF
-18.52
Quick Ratio
0.64
Current Ratio
0.76
Debt / Equity
1.24
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.12
EPS next Y
-
EPS next Q
-
EPS this Y
102.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
6.68%
Revenue Q/Q
-43.25%
EPS Q/Q
-293.33%
-
-
-
-
SMA20
-14.83%
SMA50
-14.83%
SMA100
-22.61%
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-18%
ROC
-0.14%
Gross Margin
5%
Oper. Margin
-9%
Profit Margin
-9%
Payout
-28%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.5-2.9
52W High
-16%
52W Low
+68%
RSI
32.18
Rel Volume
0.22
Avg Volume
153.94M
Volume
34.22M
Perf Week
-9.68%
Perf Month
-19.23%
Perf Quarter
-21.5%
Perf Half Y
-25.66%
-
-
-
-
Beta
1.085
-
-
Volatility
0.07%, 0.13%
Prev Close
-1.75%
Price
1.68
Change
-4%
002610.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.17 | 1.14 | 0.67 | 0.56 | 1.5 | |
| Net income per share | 0.03 | -0.37 | 0.01 | -0.09 | -0.19 | |
| Operating cash flow per share | 0.21 | 0.18 | 0.13 | 0.12 | 0.04 | |
| Free cash flow per share | -0.01 | 0.03 | 0.04 | 0.04 | -0.02 | |
| Cash per share | 0.5 | 0.22 | 0.14 | 0.2 | 1.09 | |
| Book value per share | 1.42 | 0.92 | 0.91 | 0.81 | 0.64 | |
| Tangible book value per share | 1.39 | 0.87 | 0.88 | 0.8 | 0.67 | |
| Share holders equity per share | 1.42 | 0.92 | 0.91 | 0.81 | 0.64 | |
| Interest debt per share | 1.23 | 0.81 | 0.68 | 0.63 | 0.79 | |
| Market cap | 6.48B | 7.21B | 14.75B | 21.06B | 12.73B | |
| Enterprise value | 8.99B | 8.98B | 16.79B | 22.48B | 13.07B | |
| P/E ratio | 51.69 | -4.32 | 499.63 | -50.17 | -15.39 | |
| Price to sales ratio | 1.34 | 1.41 | 4.89 | 8.32 | 1.9 | |
| POCF ratio | 7.46 | 8.73 | 25.25 | 39.29 | 69.23 | |
| PFCF ratio | -145.84 | 63.91 | 73.9 | 127.94 | -141.57 | |
| P/B Ratio | 1.1 | 1.75 | 3.6 | 5.79 | 4.45 | |
| PTB ratio | 1.1 | 1.75 | 3.6 | 5.79 | 4.45 | |
| EV to sales | 1.86 | 1.75 | 5.57 | 8.88 | 1.95 | |
| Enterprise value over EBITDA | 7.48 | 261.89 | 24.33 | 399.84 | -47.22 | |
| EV to operating cash flow | 10.35 | 10.88 | 28.73 | 41.93 | 71.05 | |
| EV to free cash flow | -202.29 | 79.59 | 84.1 | 136.53 | -145.29 | |
| Earnings yield | 0.02 | -0.23 | 0 | -0.02 | -0.06 | |
| Free cash flow yield | -0.01 | 0.02 | 0.01 | 0.01 | -0.01 | |
| Debt to equity | 0.78 | 0.78 | 0.65 | 0.71 | 1.16 | |
| Debt to assets | 0.32 | 0.28 | 0.28 | 0.28 | 0.29 | |
| Net debt to EBITDA | 2.09 | 51.59 | 2.95 | 25.16 | -1.21 | |
| Current ratio | 1.16 | 1.07 | 1.03 | 0.98 | 0.86 | |
| Interest coverage | 0.34 | -0.58 | 1.16 | -0.31 | -3.88 | |
| Income quality | 6.3 | -0.49 | 19.79 | -1.28 | -0.22 | |
| Dividend Yield | 0.08 | 0.06 | 0.03 | 0.01 | 0.01 | |
| Payout ratio | 3.89 | -0.26 | 12.65 | -0.58 | -0.2 | |
| Sales general and administrative to revenue | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -1.05 | -0.86 | -0.66 | -0.69 | -1.49 | |
| Capex to revenue | -0.19 | -0.14 | -0.13 | -0.15 | -0.04 | |
| Capex to depreciation | -2.05 | -2.53 | -1.58 | -2.7 | -1.5 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.04 | 0.01 | |
| Graham number | 0.99 | 2.77 | 0.37 | 1.31 | 1.63 | |
| ROIC | 0.01 | -0.03 | -0.05 | -0.01 | -0.12 | |
| Return on tangible assets | 0.01 | -0.15 | 0 | -0.05 | -0.07 | |
| Graham Net | -0.76 | -0.95 | -0.43 | -0.55 | -0.24 | |
| Working capital | 880.08M | 312.37M | 145.31M | -97.37M | -1.05B | |
| Tangible asset value | 5.74B | 3.88B | 3.93B | 3.57B | 2.99B | |
| Net current asset value | -1.68B | -2.73B | -757.41M | -1.29B | -1.79B | |
| Invested capital | 0.78 | 0.78 | 0.65 | 0.71 | 1.16 | |
| Average receivables | 3.13B | 3.29B | 3.34B | 3.09B | 2.57B | |
| Average payables | 1.44B | 1.46B | 1.3B | 1.13B | 2.27B | |
| Average inventory | 267.03M | 259.56M | 206.44M | 299.52M | 518.97M | |
| Days sales outstanding | 280.92 | 203.39 | 462.6 | 339.15 | 151.81 | |
| Days payables outstanding | 114.27 | 139.5 | 131.88 | 197.36 | 173.25 | |
| Days of inventory on hand | 25.6 | 20.04 | 24.49 | 63.08 | 33.03 | |
| Receivables turnover | 1.3 | 1.79 | 0.79 | 1.08 | 2.4 | |
| Payables turnover | 3.19 | 2.62 | 2.77 | 1.85 | 2.11 | |
| Inventory turnover | 14.26 | 18.22 | 14.91 | 5.79 | 11.05 | |
| ROE | 0.02 | -0.41 | 0.01 | -0.12 | -0.29 | |
| Capex per share | -0.22 | -0.16 | -0.09 | -0.08 | -0.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.43 | 0.53 | 0.28 | 0.35 | 0.2 | |
| Net income per share | -0.03 | -0.12 | 0.01 | 0 | -0.01 | |
| Operating cash flow per share | -0.03 | -0.12 | 0.01 | 0.08 | -0.05 | |
| Free cash flow per share | -0.04 | -0.13 | 0 | 0.07 | -0.08 | |
| Cash per share | 0.73 | 1.09 | 0.54 | 0.44 | 0.4 | |
| Book value per share | 0.75 | 0.64 | 0.65 | 0.65 | 0.64 | |
| Tangible book value per share | 0.78 | 0.67 | 0.68 | 0.68 | 0.67 | |
| Share holders equity per share | 0.75 | 0.64 | 0.65 | 0.65 | 0.64 | |
| Interest debt per share | 0.81 | 0.76 | 0.89 | 0.87 | 0.81 | |
| Market cap | 13.53B | 12.73B | 13.09B | 11.44B | 10.59B | |
| Enterprise value | 13.85B | 13.07B | 14.32B | 13.03B | 12.11B | |
| P/E ratio | -26.87 | -5.82 | 100.39 | 210.7 | -102.06 | |
| Price to sales ratio | 7.08 | 5.38 | 10.52 | 7.25 | 11.82 | |
| POCF ratio | -107.46 | -23.29 | 401.55 | 31.45 | -44.71 | |
| PFCF ratio | -68.86 | -21.39 | 1.37K | 35.36 | -31.37 | |
| P/B Ratio | 4.07 | 4.45 | 4.53 | 3.93 | 3.68 | |
| PTB ratio | 4.07 | 4.45 | 4.53 | 3.93 | 3.68 | |
| EV to sales | 7.25 | 5.52 | 11.51 | 8.26 | 13.53 | |
| Enterprise value over EBITDA | -167.29 | -37.79 | 156.54 | 194.01 | 658.97 | |
| EV to operating cash flow | -110 | -23.9 | 439.23 | 35.83 | -51.15 | |
| EV to free cash flow | -70.49 | -21.96 | 1.5K | 40.28 | -35.89 | |
| Earnings yield | -0.01 | -0.04 | 0 | 0 | 0 | |
| Free cash flow yield | -0.01 | -0.05 | 0 | 0.03 | -0.03 | |
| Debt to equity | 1.07 | 1.16 | 1.35 | 1.32 | 1.24 | |
| Debt to assets | 0.29 | 0.29 | 0.34 | 0.33 | 0.31 | |
| Net debt to EBITDA | -3.85 | -0.97 | 13.43 | 23.72 | 83 | |
| Current ratio | 0.86 | 0.86 | 0.82 | 0.78 | 0.76 | |
| Interest coverage | -2.89 | -8.68 | 0.86 | 0.37 | -1.31 | |
| Income quality | 1 | 1 | 1 | 26.8 | 9.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.28 | -0.04 | 1.22 | 3.33 | -1.57 | |
| Sales general and administrative to revenue | 0.06 | -0.02 | 0.04 | -0.01 | 0.13 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | 0.56 | 0.09 | -0.71 | -0.11 | 0.43 | |
| Capex to revenue | -0.04 | -0.02 | -0.02 | -0.03 | -0.11 | |
| Capex to depreciation | -1.23 | -0.84 | -0.45 | -0.79 | 1.08 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.69 | 1.33 | 0.33 | 0.21 | 0.29 | |
| ROIC | -0.02 | -0.08 | 0 | 0 | -0.01 | |
| Return on tangible assets | -0.01 | -0.05 | 0 | 0 | 0 | |
| Graham Net | -0.69 | -0.24 | -0.78 | -0.83 | -0.86 | |
| Working capital | -1.1B | -1.05B | -1.39B | -1.71B | -1.89B | |
| Tangible asset value | 3.48B | 2.99B | 3.02B | 3.03B | 3B | |
| Net current asset value | -1.89B | -1.79B | -2.07B | -2.22B | -2.44B | |
| Invested capital | 1.07 | 1.16 | 1.35 | 1.32 | 1.24 | |
| Average receivables | 2.55B | 2.74B | 2.71B | 2.9B | 3.17B | |
| Average payables | 2.63B | 3.12B | 3.05B | 2.94B | 3.02B | |
| Average inventory | 789.41M | 632.52M | 628.59M | 552.62M | 515.73M | |
| Days sales outstanding | 126.66 | 105.83 | 190.4 | 181.09 | 317.52 | |
| Days payables outstanding | 142.14 | 120.26 | 241.71 | 186.62 | 330.93 | |
| Days of inventory on hand | 30.71 | 22.93 | 54.07 | 28.58 | 62.08 | |
| Receivables turnover | 0.71 | 0.85 | 0.47 | 0.5 | 0.28 | |
| Payables turnover | 0.63 | 0.75 | 0.37 | 0.48 | 0.27 | |
| Inventory turnover | 2.93 | 3.93 | 1.66 | 3.15 | 1.45 | |
| ROE | -0.04 | -0.19 | 0.01 | 0 | -0.01 | |
| Capex per share | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
002610.SZ Frequently Asked Questions
What is Jiangsu Akcome Science and Technology Co., Ltd. stock symbol ?
Jiangsu Akcome Science and Technology Co., Ltd. is a CN stock and trading under the symbol 002610.SZ
What is Jiangsu Akcome Science and Technology Co., Ltd. stock quote today ?
Jiangsu Akcome Science and Technology Co., Ltd. stock price is $1.68 today.
Is Jiangsu Akcome Science and Technology Co., Ltd. stock public?
Yes, Jiangsu Akcome Science and Technology Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 153.94M
- Market Capitalization 8.13B
- Employee 1.48K
- CEO Mr. Chenghui Zou
- Headquarters Zhangjiagang,CN
- IPO Date 2011-08-15
-
Website
https://www.akcome.com 
Jiangsu Akcome Science and Technology Co., Ltd. manufactures photovoltaic solar accessories in the People's Republic of China. It also operates photovoltaic power stations. Jiangsu Akcome Science and Technology Co., Ltd. was founded in 2006 and is headquartered in Zhangjiagang, the People's Republic of China.
